'Cautiously optimistic' over Pfizer-AstraZeneca deal: Pro

7:00 PM ET Thu, 8 May 2014

Mark Artus, CEO of 1HQ, discusses the implications behind the possible acquisition of Pfizer by AstraZeneca.